Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Bankable Feasibility Study

15 Jan 2008 11:04

Ovoca Gold PLC15 January 2008 Ovoca Gold plc Bankable Feasibility Study Results for Goltsovoye: cash cost of production $4.11 per ounce of silver, pre-production capital cost of $73.9million, average production 6.4 million ounces of silver a year in early years. Ovoca Gold Plc, the London AIM (OVG.L) and IEX (OVX.IR) ("Ovoca") is pleased toannounce the results of the Bankable Feasibility Study (BFS) for itswholly-owned Goltsovoye silver project; prepared by Scott Wilson Ltd. Scott Wilson concludes: "The Goltsovoye project presents an opportunity todevelop an economically viable project for Ovoca that has the potential toprovide economic returns on investment. Based on Zone 1 resources, the cashflow analysis indicated robust project economics across a range of silver priceassumptions." The BFS states that the Goltsovoye mine project has apre-production capital cost of $73.9 million (without a 10% contingency). Theaverage production cost will be $4.11 per ounce of silver. Output will be over6.4 million ounces of silver per year for the first three years of operation.Scott Wilson's base case NPV for Goltsovoye at $12.50 per ounce of silver and ata 10% discount rate is $75.9 million on a pre income tax basis. At a $15 perounce silver price and a lead price of $772 per tonne (current prices are $16.15and $3453 respectively) and 10% discount rate, Goltsovoye's NPV, on a pre incometax basis, is $128.6 million. Internal Rate of return (IRR) and pre income tax Net Present Value (NPV) Silver Price USD per ounce Variation IRR NPV USD millions $10.00 -20% 22.4% 23.1 $11.25 -10% 34.8% 49.5 Base Case $12.50 0 46.3% 75.9 $13.75 +10% 57.1% 102.3 $15.00 +20% 67.5% 128.6 It is important to note that the BFS addresses only the first phase developmentof the Goltsovoye deposit, Ore Zone 1 resources, containing 41.3 million ouncesof silver measured and indicated, at 884 grams per tonne (Canadian NI 43-101standard). The BFS does not include Ore Zone 1 inferred resources of 3.2 millionounces of silver at 627 grams per tonne; Ore Zone 2 JORC catagorised resourcespreviously announced by Ovoca Gold in Q107, of 22 million ounces of silver (2.7indicated, 19.4 inferred) at 754 grams per tonne, or any of the 4 otheridentified Ore Zones. In the Study, Goltsovoye is designed as a compact underground operation, with anannual mined output of 260,000 tonnes of ore during the six-year mine life ofOre Zone 1. Ore processing is a combination of gravitation and flotation withthe end product being a silver-lead concentrate. Silver recoveries arepredicted to be 95% while lead recoveries are predicted at between 76% and 86%.The process plant will consist of three stage crushing and grinding, followed bythe gravitation and flotation circuits to produce two separate products: agravity concentrate and a flotation concentrate. Special attention has been paid to the environmental aspects of the project.Scott Wilson comments in the BFS: "Based on the information gathered to date, itis considered likely that environmental impacts arising from the project can beavoided or mitigated against in the project design and as such will notcompromise the success of the project." The tailings storage facility is contained as a valley dam with a rockfillembankment. Power will be supplied from six 1750 kV diesel generators. Processwater and potable water will be supplied from wells, and the process water willbe recycled from the tailings pond. A permanent man camp will house 260employees. The mine will directly employ 371 people (331 mining and processing)and will work a two-week-on-two-week-off rotating schedule. Leonid Skoptsov, Chief Executive Officer of Ovoca comments: "I am very pleasedwith the results of Scott Wilson's BFS, which confirms the attractiveness of ourGoltsovoye project. Even with a base case scenario of $12.50 per ounce ofsilver, Goltsovoye is a world-class property that would be a welcome addition inthe asset portfolio of any mining company. Of course, considering that silver isnow above $16/oz and above the top range for the BFS, I believe that Goltsovoyewill demonstrate financial performance in excess of the already robust economicsconcluded by Scott Wilson. I look forward to building Goltsovoye, and deliveringon our promises to shareholders, the local community and employees to create afirst-rate company around this wonderful asset that Ovoca has the good fortuneto own." The Executive Summary of the BFS can be viewed on the company's website:www.ovocagold.com. The above information has been reviewed and verified by Roger Turner, Chairmanand Director of Ovoca, for the purposes of Mining, Oil and Gas Companies issuedby The London Stock Exchange in March 2006. Mr. Turner with 41 years miningengineering, management and consulting experience, graduated as a miningengineer from the Camborne School of Mines and has an MSc degree in EconomicGeology from Leicester University. He is a member in good standing of theInstitute of Materials, Mining and Metallurgy and is a UK Chartered Engineer. Ovoca Gold Plc is an international exploration company with dual listing inLondon (OVG.L) and Ireland (OVX.IR), exploring for and developing precious andbase metals properties in Russia. For further information please visit www.ovocagold.com or contact: Leonid Skoptsov - Ovoca Gold PlcTel + 7 (0)495 648 2646Email: leonid.skoptsov@ovocagold.com John Frain - DavyTel : +353 (0)1 679 6363Email: john.frain@davy.ie John O'Connor - Ovoca Gold PlcTel: +353 (0)1 633 0523Email: john.oconnor@ovocagold.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.